153 related articles for article (PubMed ID: 27017553)
1. Novel hederagenin-triazolyl derivatives as potential anti-cancer agents.
Rodríguez-Hernández D; Demuner AJ; Barbosa LC; Heller L; Csuk R
Eur J Med Chem; 2016 Jun; 115():257-67. PubMed ID: 27017553
[TBL] [Abstract][Full Text] [Related]
2. Hederagenin as a triterpene template for the development of new antitumor compounds.
Rodríguez-Hernández D; Demuner AJ; Barbosa LC; Csuk R; Heller L
Eur J Med Chem; 2015 Nov; 105():57-62. PubMed ID: 26476750
[TBL] [Abstract][Full Text] [Related]
3. Leishmanicidal and cytotoxic activity of hederagenin-bistriazolyl derivatives.
Rodríguez-Hernández D; Barbosa LCA; Demuner AJ; Nain-Perez A; Ferreira SR; Fujiwara RT; de Almeida RM; Heller L; Csuk R
Eur J Med Chem; 2017 Nov; 140():624-635. PubMed ID: 29024910
[TBL] [Abstract][Full Text] [Related]
4. Hederagenin amide derivatives as potential antiproliferative agents.
Rodríguez-Hernández D; Barbosa LCA; Demuner AJ; Ataide Martins JP; Fischer Nee Heller L; Csuk R
Eur J Med Chem; 2019 Apr; 168():436-446. PubMed ID: 30840925
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of ursolic acid-triazolyl derivatives as potential anti-cancer agents.
Rashid S; Dar BA; Majeed R; Hamid A; Bhat BA
Eur J Med Chem; 2013 Aug; 66():238-45. PubMed ID: 23811086
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of novel α-hederagenin derivatives with anticancer activity.
Liu XX; Yang YT; Wang X; Wang KY; Liu JQ; Lei L; Luo XM; Zhai R; Fu FH; Wang HB; Bi Y
Eur J Med Chem; 2017 Dec; 141():427-439. PubMed ID: 29040953
[TBL] [Abstract][Full Text] [Related]
7. A library of 1,2,3-triazole-substituted oleanolic acid derivatives as anticancer agents: design, synthesis, and biological evaluation.
Wei G; Luan W; Wang S; Cui S; Li F; Liu Y; Liu Y; Cheng M
Org Biomol Chem; 2015 Feb; 13(5):1507-14. PubMed ID: 25476168
[TBL] [Abstract][Full Text] [Related]
8. Highly potent anti-leishmanial derivatives of hederagenin, a triperpenoid from Sapindus saponaria L.
Rodríguez-Hernández D; Barbosa LCA; Demuner AJ; de Almeida RM; Fujiwara RT; Ferreira SR
Eur J Med Chem; 2016 Nov; 124():153-159. PubMed ID: 27569196
[TBL] [Abstract][Full Text] [Related]
9. Targeting cancer cells with oleanolic and ursolic acid derived hydroxamates.
Wiemann J; Heller L; Csuk R
Bioorg Med Chem Lett; 2016 Feb; 26(3):907-909. PubMed ID: 26750249
[TBL] [Abstract][Full Text] [Related]
10. A Novel Method to Synthesize 4-Aryl-1H-1,2,3-Triazoles and its Antihepatoma Activity.
Li X; He Y; Hai L; Zhang T; Wu Y
Anticancer Agents Med Chem; 2016; 16(12):1622-1627. PubMed ID: 26592747
[TBL] [Abstract][Full Text] [Related]
11. Click chemistry inspired facile synthesis and bioevaluation of novel triazolyl analogs of Ludartin.
Lone SH; Bhat KA; Majeed R; Hamid A; Khuroo MA
Bioorg Med Chem Lett; 2014 Feb; 24(4):1047-51. PubMed ID: 24484897
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Characterization and Anti-hepatoma Activity of New Hederagenin Derivatives.
Liu X; Sun L; Liu QH; Chen BQ; Liu YM
Mini Rev Med Chem; 2020; 20(3):252-257. PubMed ID: 32134368
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents.
Reddy PB; Agrawal SK; Singh S; Bhat BA; Saxena AK; Kumar HM; Qazi GN
Chem Biodivers; 2008 Sep; 5(9):1792-802. PubMed ID: 18816530
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of novel isoxazoles and triazoles linked 6-hydroxycoumarin as potent cytotoxic agents.
Shakeel-u-Rehman ; Masood-ur-Rahman ; Tripathi VK; Singh J; Ara T; Koul S; Farooq S; Kaul A
Bioorg Med Chem Lett; 2014 Sep; 24(17):4243-6. PubMed ID: 25088398
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
Hao J; Liu J; Wen X; Sun H
Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227
[TBL] [Abstract][Full Text] [Related]
17. Synthesis by microwave-assisted 1,3-dipolar cycloaddition of 1,2,3-triazole 1'-homo-3'-isoazanucleosides and evaluation of their anticancer activity.
Ferreira da Costa J; García-Mera X; Caamaño O; Brea JM; Loza MI
Eur J Med Chem; 2015 Jun; 98():212-20. PubMed ID: 26025141
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, determination of the lipophilicity, anticancer and antimicrobial properties of some fused 1,2,4-triazole derivatives.
Sztanke K; Tuzimski T; Rzymowska J; Pasternak K; Kandefer-Szerszeń M
Eur J Med Chem; 2008 Feb; 43(2):404-19. PubMed ID: 17531354
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor activity evaluation of novel oleanolic acid derivatives.
Meng YQ; Zhao YW; Kuai ZY; Liu LW; Li W
J Asian Nat Prod Res; 2017 Oct; 19(10):1000-1010. PubMed ID: 28140665
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of antitumour (1H-1,2,3-triazol-4-yl)-4-hydroxycyclohexa-2,5-dien-1-ones by copper-catalysed Huisgen cycloadditions.
McCarroll AJ; Matthews CS; Wells G; Bradshaw TD; Stevens MF
Org Biomol Chem; 2010 May; 8(9):2078-84. PubMed ID: 20401384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
